# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA616832 | B | Compound was tested for binding affinity towards 5-HT1C (5-HT1C) receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand | Rattus norvegicus | 1 | assay format | Scientific Literature | ||
2. | ALA616834 | B | Binding affinity towards 5-hydroxytryptamine 1C receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand | Rattus norvegicus | 28 | assay format | Scientific Literature | ||
3. | ALA617438 | B | Binding affinity towards 5-hydroxytryptamine 2 receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand | 27 | assay format | Scientific Literature | |||
4. | ALA858114 | B | Affinity against 5-hydroxytryptamine 2B receptor in the isolated rat stomach fundus | 19 | tissue-based format | Scientific Literature | |||
5. | ALA619177 | B | Affinity against 5-hydroxytryptamine receptors in rat fundus model | 44 | assay format | Scientific Literature | |||
6. | ALA631963 | F | Log value of hallucinogenic activity was determined | Homo sapiens | 63 | organism-based format | Scientific Literature | ||
7. | ALA633218 | P | Partition coefficient (logP) | 19 | small-molecule physicochemical format | Scientific Literature | |||
8. | ALA696016 | F | Hallucinogenic activity i.e; ratio of effective dose of mescaline to the effective dose in human | Homo sapiens | 63 | organism-based format | Scientific Literature | ||
9. | ALA878435 | F | Human hallucinogenic activity relative to mescaline | Homo sapiens | 15 | organism-based format | Scientific Literature | ||
10. | ALA700102 | F | Compound tested for hallucinogenic activity in humans was reported; Value reported in (A)= Mescaline units | Homo sapiens | 91 | organism-based format | Scientific Literature | ||
11. | ALA750801 | B | Compound was tested for the ability to inhibit [3H]norepinephrine binding to Norepinephrine transporter in rat synaptosomes | 6 | subcellular format | Scientific Literature | |||
12. | ALA773948 | F | Hyperthermic potency in rabbit relative to DOM | Oryctolagus cuniculus | 18 | organism-based format | Scientific Literature | ||
13. | ALA784676 | F | Compound was tested for hallucinogenic activity in rats at 0.32(mg/kg) | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
14. | ALA785266 | F | Compound was tested for hallucinogenic activity in rats at the dose 0 (mg/kg) | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
15. | ALA781226 | F | Effective dose for drug discrimination assay in rats using (+)-Amphitamine as training drug; NS = No substitution | Rattus norvegicus | 4 | organism-based format | Scientific Literature | ||
16. | ALA782002 | F | Effective dose in rats trained on 1 mg/kg DOM. | Rattus norvegicus | 16 | organism-based format | Scientific Literature | ||
17. | ALA779591 | F | Compound was tested for its ability to inhibit [3H]dopamine uptake in rat synaptosomes | Rattus norvegicus | 7 | organism-based format | Scientific Literature | ||
18. | ALA783646 | F | Inhibitory concentration against [3H]- 5-HT uptake in crude rat synaptosomes | Rattus norvegicus | 4 | organism-based format | Scientific Literature | ||
19. | ALA872034 | F | Inhibitory concentration against [3H]- DA uptake in crude rat synaptosomes | Rattus norvegicus | 3 | organism-based format | Scientific Literature | ||
20. | ALA783648 | F | Inhibitory concentration against [3H]- NE uptake in crude rat synaptosomes | Rattus norvegicus | 4 | organism-based format | Scientific Literature |